McNeil Healthcare, LLC FDA Inspection Record
McNeil Healthcare, LLC is an FDA-inspected facility (FEI 2650141) located in Las Piedras, PR, US. RegDataLab tracks 9 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Sep 20, 2023: Voluntary Action Indicated (VAI)
- Inspections on record
- 9 (2 OAI, 4 VAI, 3 NAI)
- Last OAI inspection
- Nov 2, 2010
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Form 483 and inspection documents
- 9 in FDA's reading room
- Recalls as the recalling firm
- 2, latest Feb 17, 2010
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 20, 2023 | Voluntary Action Indicated (VAI) | No citations listed |
| Mar 31, 2021 | Voluntary Action Indicated (VAI) | No citations listed |
| Jun 21, 2018 | No Action Indicated (NAI) | No citations listed |
| Mar 31, 2015 | No Action Indicated (NAI) | No citations listed |
| Aug 27, 2013 | No Action Indicated (NAI) | No citations listed |
| Oct 26, 2011 | Voluntary Action Indicated (VAI) | Investigations of discrepancies, failures (21 CFR 211.192) |
| Nov 2, 2010 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) SOPs not followed / documented (21 CFR 211.100(b)) Following/documenting laboratory controls (21 CFR 211.160(a)) Failing drug products not rejected (21 CFR 211.165(f)) and 4 more |
| Feb 3, 2010 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) |
| Jan 8, 2010 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Written procedures not established/followed (21 CFR 211.67(b)) Investigations of discrepancies, failures (21 CFR 211.192) Extent of discrepancy, failure investigations (21 CFR 211.192) and 3 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Feb 17, 2010 | Class II | D-696-2010 | Motrin IB (Ibuprofen) Caplets USP, 200mg, Pain Reliever/Fever Reducer (NSAID), 24 Coated… Failed Dissolution Specification |
| Dec 19, 2002 | Class III | D-107-3 | Tylenol PM Extra Strength Geltabs (Acetaminophen 500 mg and Diphenhydramine HCL 25 mg)… Dissolution; failure to meet specification at 18 month timepoint |
Form 483s and inspection documents
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 14, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 14, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 2, 2026 | Newest record Oct 22, 2026 | Current |
Reviewing McNeil Healthcare, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check McNeil Healthcare, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- McNeil Healthcare, LLC
- Location
- Las Piedras, PR (US)
- Source
- inspections